Comparison of Two Intensified Regimens in Advanced Urothelial Cancer: A Prospective, Randomized, Phase 3 Study - MPR
Links shared publicly online about this topic.
- 238total visits
Comparison of Two Intensified Regimens in Advanced Urothelial Cancer: A Prospective, Randomized, Phase 3 Study - MPR
empr.com —
Dose dense (DD) gemcitabine/cisplatin therapy was not superior to DD methotrexate/vinblastine/doxorubicin HCl/cisplatin in patients with inoperable or recurrent urothelial cancer; however, the former was better tolerated, results of a Phase 3 randomized trial presented at the American Society of Clinical Oncology’s 2011 Annual Meeting have found.
View full resource at empr.com
Tags: Cancer, Phase 3 Clinical Trial, News
Most Recently Shared on June 6, 2011 at 9:01 pm By:
#asco2011 Comparison of Two Intensified Regimens in Advanced Urothelial Cancer: A Prospective… http://goo.gl/fb/jQTUc
Advertisement
